Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid LeukemiaScott B Hoyt, Chris J Finocchio, Elizabeth Croll, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Microorganisms|April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In VivoCourtney L Finch, Julie Dyall, Shuang Xu, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Nature Communications|September 17, 2022
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Cancer Cell|May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaMichail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Scientific Reports|November 24, 2018
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H Jansson, John B Tucker, Lauren E Stahl, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid LeukemiaScott B Hoyt, Chris J Finocchio, Elizabeth Croll, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Microorganisms|April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In VivoCourtney L Finch, Julie Dyall, Shuang Xu, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Nature Communications|September 17, 2022
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Cancer Cell|May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaMichail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Scientific Reports|November 24, 2018
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H Jansson, John B Tucker, Lauren E Stahl, et al.
Pageof 23